LOCAL medical marijuana company, Medicanja Limited, expects to generate approximately $4 billion in sales within four years.
“Revenue from the sales and services of over 18 products that we have planned from Medicanja limited, including six product lines, will be in excess of $4 billion,” said the executive chairman of Medicanja Limited, Dr Henry Lowe.
What’s more, during the first quarter of next year, Medicanja plans to launch an initial public offering (IPO) to raise funds from the market to continue product development and research.
“This will give Jamaicans at home and in the Diaspora a chance to invest” in a product that shares a strong brand association with the country, he said. Continue
SOURCE: Jamaica Observer